
==== Front
Clin Oral Investig
Clin Oral Investig
Clinical Oral Investigations
1432-6981
1436-3771
Springer Berlin Heidelberg Berlin/Heidelberg

39182209
5880
10.1007/s00784-024-05880-3
Research
Comparison of clinical parameters of peri-implantitis and parameters related to tissue macrophage sensitization on TiO2
Sahrmann Philipp Philipp.sahrmann@unibas.ch

1
Tartsch Jens 2
Schmidlin Patrick R. 3
1 https://ror.org/02s6k3f65 grid.6612.3 0000 0004 1937 0642 Department of Periodontology, Endodontology and Cariology, University Centre for Dental Medicine, University of Basel, Basel, Switzerland
2 Private Practice, Kilchberg, Switzerland
3 https://ror.org/02crff812 grid.7400.3 0000 0004 1937 0650 Clinic of Conservative and Preventive Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland
25 8 2024
25 8 2024
2024
28 9 49918 1 2024
6 8 2024
© The Author(s) 2024, corrected publication 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Objective

Dental implants show impressive survival and like rates, but peri-implantitis is a frequent inflammatory disease which affects the implant-surrounding tissues. While biofilms on the implant surface is considered its etiologic reason, several risk factors determine the pace of progression of peri-implant bone loss. Some risk factors are generally accepted while others are still unconfirmed and a matter of ongoing discussion. Among the latter, tissue macrophage sensitization on TiO2 has gained scientific interest in recent years. The aim of the present case-control study was to test for potential associations between clinically manifest peri-implantitis and MS related parameters.

Materials and methods

In patients with implants affected by peri-implantitis in the test group and healthy implants in the control group clinical parameters (peri-implant pocket depths (PPD) and bleeding on probing (BOP) were measured. Samples of aMMP-8 were taken from the entrance of the peri-implant sulcus and bacterial samples were collected from the sulcus. Blood samples were obtained from the basilic vein to assess MA-related laboratory parameters. Potential correlations between clinical and laboratory parameters were tested by multiple regression (p < 0.05).

Results

No statistically significant correlations were found between clinical or bacteriological findings and laboratory parameters were found.

Conclusions

Based on the findings of this study elevated MA-related laboratory parameters do not appear to be linked to peri-implantitis.

Clinical relevance

Sensitization on TiO2 is not associated with clinical symptoms of peri-implantitis.

Keywords

Peri-implantitis
Macrophage sensitization
Titanium dioxide
Risk factors
University of BaselOpen access funding provided by University of Basel

issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmcIntroduction

Dental implants have demonstrated impressive survival and success rates [1–5] However, they are not without flaws, and various complications are frequently reported in clinical studies [6, 7]. Of these, complications of biologic nature are not only the most frequent ones but also often most difficult to manage [8, 9]. Within the biologic complications, peri-implant inflammations affecting the soft and hard tissues surrounding the implant are the most prevalent and potentially impactful, leading to implant failure and loss [5]. The minor or initial form, peri-implant mucositis, only affects the marginal host tissues, does not constitute a clinical problem for implant success and survival per se but is of utmost importance as an easy-to-treat precursor of peri-implantitis. The latter however affects all peri-implant tissues and results in the - largely irreversible - downgrowth of the bony implant attachment [9, 10]. Today peri-implantitis with a weighted mean prevalence of 22% [11] is a frequent and clinically most relevant challenge in dental practice [12].

The primary etiologic reason for these inflammatory diseases is biofilm which colonizes the implant surfaces and triggers the response of the host’s immune defense mechanisms [13, 14]. The dynamics of the disease however, i.e., the progressive destruction of the bony implant attachment, are determined by a broad variety of risk factors. History of periodontitis, smoking and diabetes mellitus are well-established and scientifically confirmed examples for such risk factors, while several further conditions have been proposed but are still lacking evidence so far [15, 16]. Among these proposed risk factors the implant material itself has gained scientific attention during the last decades [17–19]. While metal alloys with a predominant proportion of titanium have been proven to be a most reliable material for both, safe osteointegration and long-term stability of dental implants, titanium particles have been shown to corrode from the surface and to disintegrate from fixture and abutment due to micromovements between fixture and abutment [20], and then spread into the peri-implant host tissues. There, they might challenge the host’s immune response. Tissue macrophages incorporate such microparticles and - as a consequence to impossible degradation of such particles - trigger an accelerated inflammatory cascade [18]. The intensity of this cascade however seems to underly strong inter-individual differences. In part, these differences are explained by the genetic configuration of areas encoding for the expression of the cytokines tnf-α and IL-1α and IL-1ß. [21] Dependent on an either mono or bi-allelic polymorphisms in these areas, the extent of the immunologic response has been reported to vary strongly in in-vitro stimulations of blood-born macrophages with TiO2. [22]. In vivo, enhanced macrophage stimulation has been reported to be associated to the loss of Brånemark implants and was proposed as independent risk factor for implant failure [21]. In a case-control study on healthy implants and implants with peri-implantitis, significant differences were found in the carriage rate of one allele of a IL-1RN encoding gene sections [23]. Titanium is no longer the only implant material available and alternative materials have gained clinical relevance. Among these, ceramic and especially ZrO2, which is meant not to induce similar immunologic reactions, have become clinically interesting and widely used. Accordingly, and with the aim to assess the prognosis of dental implants in the individual, a macrophage stimulation test on TiO2 has been proclaimed an important measure before implant therapy. Depending on the result the choice of ceramic as an alternative has been suggested if the patient shows respective polymorphisms and an accelerated immunologic response [24, 25].

However, the issue remains controversial based on recent reviews, and whether polymorphisms in the encoding sections for IL-1ß and tnf-α are in fact having an effect on or whether they are associated with peri-implant inflammations [16, 26–28] is still matter of ongoing discussion. These reviews do accord, however, on the fact that further clinical data is needed to understand the potential impact of such polymorphisms.

Therefore, it was the aim of the present case control study to assess a potential correlation of the of peri-implant health and TiO2-sensitisation-related parameters.

Materials and methods

The hypothesis of the present study was, that patients with clinical symptoms of peri-implantitis display a higher degree of gene section polymorphisms encoding for the pivotal cytokines tnf-α and IL and related cytokine reactions on TiO2. Prior to study start an ethics approval was obtained by the Ethical Committee of the Canton of Zurich (KEK-ZH-Nr. 2014 − 0133).

Patients presenting themselves with dental implants in the Clinic of Conservative and Preventive Dentistry at the Center of Dental Medicine of the University of Zurich were asked to participate. They were informed about the aim of the study and the respective study-specific measures, and eventually gave their written consent to participate.

Patient participation was strictly voluntary.

Patient screening

The study inclusion criteria comprised at least one dental implant which had been loaded for at least 24 months. Patient had to be older than 18y of age and able to understand the patient information (written in German). Exclusion criteria consisted of intake of systemic antibiotics or any peri-implantitis treatment in the previous 6 months. Patients with anticoagulation medication other than 100 mg of acetylsalicylic acid per day were excluded in order not to face problems after blood sampling were excluded, and patients with systemic medication for immune suppression since their immunologic response might not be representative. Heavy smokers (> 10 cigarettes/day) and patients with suspect for implant fracture were excluded likewise.

In patients presenting with implants, examinations were conducted by specialists in periodontitis and sound clinical expertise in peri-implantitis (PRS, PSA), both of which were trained to apply a probing force of 0.2 N. Probing depths were measured around the implant and at the neighboring teeth, and pus secretion and bleeding on probing was recorded.

Additionally, a radiograph of the implant was taken in right-angle technique and the marginal bone level around the implants was assessed.

Peri-implantitis was diagnosed when peri-implant pocket depths exceeded 4 mm accompanied by bleeding on probing and marginal bone loss around the implants as compared to either previous radiographs or in terms of localized vertical bone defects or deviations from the ideal bone level at the implant’s shoulder. Based on the diagnosis, patients were allocated to either the test group with peri-implantitis, or the control group if they presented with healthy peri-implant tissues.

Study-related treatment

In the first study-related appointment, the implant was isolated with cotton rolls and then cleaned and dried supra-mucosally with cotton pellets. In order to assess the degree of inflammation in the peri-implant tissues a sample of sulcus fluid for aMMP-8 assessment was taken using respective paper strips which were provided by the laboratory (IMD Labor Berlin, Germany). Paper stripes were placed in the entrance of the sulcus for 30s and then removed for further analysis. To better characterize the features of peri-implant biofilms, paper tips were inserted to the peri-implant sulcus floor for bacterial analysis and removed after 10 s. Both samples were stored in separate tubes, which were labelled with the study-specific identification number. The number of bleeding sites after probing and the number of pocket depths exceeding 4 mm at the implant and the neighboring teeth were recorded. Three blood samples were drawn from the medial cephalic or cubital vein for the analysis of IgA, macrophage stimulation test on TiO2 (tnf-α and IL-ß) and the analysis of the genetic cytokine profile. Therefore, a tourniquet was applied to the upper arm and the extraction site was disinfected with Kodan forte® (Schülke & Meyer GmbH, Norderstedt, Germany). The vein was punctured once only and three vacuette sampling tubes for the different laboratory assessments were drawn. Immediately after sampling, the needle was removed from the vein and the extraction site was compressed gently for 3 min.

Immediately after drawing the samples collection tubes were gently agitated and then labelled with the respective ID. Before shipping, samples were kept in a fridge at 7° until the courier collected the samples. Delivery to the 850 km distant laboratory (IMD Labor Berlin, Germany) was performed by an overnight courier in refrigerated lorries. The samples were processed there the following day.

In the laboratory, the gene sections encoding for IL-1ß and tnf-α were analyzed for bi-allelic polymorphisms at position + 3954 (TaqI restriction fragment length polymorphism) within exon 5 within the promoter region of the IL-1ß since these areas have been reported to be associated with an enhanced inflammatory response [29, 30]. The penta-allelic variable number of the tandem repeat polymorphism within the second intron of the IL-1RN gene and at position − 889 in the promoter region of the IL-1 α gene were also analyzed [31, 32]. Microbiologic assessment was performed using RNA-based amplification of defining specific gene sections by polymerase chain reaction (PCR). The specific analysis comprised the detection of the species Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Prevotella intermedia, Parvimonas micra, Fusobacterium spp., Campylobacter rectus/showa, Eubacterium nodatum, Eikenella corrodens and Capnocytophaga gingivalis/ochracea. The laboratory’s detection report provided a semi-quantitative assessment categorized as “in the normal range” (considered as 0), or “low”, “moderate”, and “strong” elevations of the respective numbers (expressed as 0.33, 0.67 and 1.00, respectively, for further statistical analysis).

Levels of aMMP-8 were determined using a commercial laboratory-based enzyme-linked immunosorbent assay (DentoElisa aMMP-8, dentodiagnostics GmbH, Solingen, Germany). IgA-levels were determined using an immune turbidity test (Alinity, Abbott, Abbott Park, Illinois, USA). Mannose binding lectin assessment was tested performed using an immunometric ELISA test read at 450 nm (MBL Oligomer ELISA Kit, Bioporto Diagnostics, Hellerup, Denmark).

Individually adapted peri-implant therapy for patients in the test group was performed subsequently after the study-specific sampling.

Statistical methods

A sample size calculation was performed prior to the study to estimate the necessary number of patients to test the study hypothesis. With an anticipated enhancement of 33% for the macrophage-secreted cytokines in the test group, as ample size of 19 for each, the test and control groups, was calculated to achieve a power of 80% and an alpha error of 5%.

Implants were defined as the statistical unit for data analysis. Due to a relatively small sample size, differences between groups were tested using the Mann-Whitney test for unpaired data, and continuous parameters such as tnf-α and IL-ß, while Pearson’s Chi-square test was used for ordinal variables such as presence of peri-implantitis or results of the molecular diagnostics.

Analyses were conducted to test a possible correlation between enhanced sensitization to TiO2 and the presence of the diagnosis of peri-implantitis. Odds ratios were calculated for the presence of peri-implantitis between both groups. The level of significance was set at 0.05. Statistical analysis was performed using the software IBM SPSS Statistics for Mac (Version 27, NY, USA).

Results

Between March 2014 and October 2021, a total of 49 patients were included in the study. Due to logistic reasons, one blood sample could not be analyzed, resulting in 24 patients in both the test and the control groups. There were no significant differences in gender, age distribution and smoking status between the two groups (Table 1). In terms of clinical parameters, the test group showed a significantly higher number of sites with probing depths exceeding 4 mm of probing depth and bleeding-on-probing as compared to the control group (p < 0.001). Additionally, several bacterial strains (P.gingivalis, T. forsythensis, T. denticola and P.micros) were found significantly more frequently in test patients than in controls (16/7, 23/6, 16/5 and 17/9, respectively) (Table 2). The concentrations of IgA, MBL and several cytokines (tnf-α, IL-1a and IL-ß a) are provided in Table 1.

Table 1 Patient characteristics, clinical findings and laboratory parameters in the different groups

Parameter	Test	Control	p-value	
Sex [n]

male/female

	10/14	14/10	0.257 a	
Age [y]

median (iqr)

	60.5 (12)	58.9 (20)	0.101 b	
PPD > 4 mm [n]

median (iqr)

	4.0 (0)	0 (0)	< 0.001 b	
IgA [mg/dL]

median (iqr)

	218 (174)	198 (100)	0.718 b	
MBL [ng/mL]

median (iqr)

	682 (2303)	459 (1551)	0.217 b	
aMMP-8 [ng/mL]

median (iqr)

	28.2 (60.7)	34 (67.7)	0.113 b	
tnf-α [pg/mL]

median (iqr)

	25.4 (37.8)	19.2 (37.1)	0.322 b	
IL-1ß [pg/mL]

median (iqr)

	18.9 (38.8)	9.5 (27)	0.367 b	
CPM

(score 0/1/2/3/4)

	9/7/3/4/1	8/8/4/4/0	0.872 c	
IL1a-polymorphism

(cc/ct/tt)

	13/12/1	14/7/3	0.320 c	
IL1ß-polymorphism

(cc/ct/tt)

	16/7/3	17/5/2	0.785 c	
IL1RA-polymorphism

(cc/ct/tt)

	2/9/15	1/9/14	0.866 c	
tnf-α-polymorphism

(aa/ga/gg)

	1/4/21	0/4/20	0.623 c	

Table 2 Bacterial assessment in the different groups

	Test	Control	p-value	
Bacterial analysis	[n]
(no/low/high/very high)	[n]
(no/low/high/very high)	p-value c	
A. actinomycetemcomitans

P. gingivalis

T. forsythensis

T. denticola

P. intermedia

P. micros

Fusobacteria spp.

C. rectus spp

E. nodatum

E. corrodens

C. gingivalis/cochracea

	22/1/0/0

8/2/1/12

2/2/9/10

8/5/4/6

16/1/2/4

8/3/5/7

2/1/10/10

11/5/7/0

20/3/0/0

14/3/6/0

19/2/0/2

	24/0/0/0

17/2/1/4

18/2/2/2

19/3/1/1

20/1/1/2

15/5/1/3

5/9/6/4

18/2/4/0

24/0/0/0

14/6/2/2

15/6/3/0

	0.302

0.065

> 0.001

0.016

0.700

0.070

0.010

0.152

0.067

0.289

0.059

	
a - Fisher’s exact test b – Mann-Whitney-u-test. c – Pearson’s Chi-square test

iqr inter quartile range, PPD Peri-implant pocket dept,; IgA immunoglobuline A, MBL mannose-binding lectine, aMMP-8 activated metallomatrix proteinase 8, tnf-α stimulated tumor necrosis factor α, IL-1ß stimulated interleucine 1ß, CPM cytokine polymorphism

Bold p-values indicate statistically significant inter-group differences

The scores for CPM levels were in the test and control groups were 9/7/3/4/1 and 8/8/4/4/0, respectively, corresponding to the scores of 0–4. The means and interquartile ranges (IQR) of aMMP8 levels in the respective groups were at 28.2 (60.7) and 34 (67.7) ng/ml. No statistically significant inter-group differences were observed for any of the assessed immunological parameters, including the cytokine polymorphism profile, IgA, mannose-binding lectin, tnf-a macrophage stimulation, IgA status, genetic cytokine profile, bacterial load or aMMP-8 (Table 2). Furthermore, when considering tnf-α values exceeding 40 pg/ml or IL-1ß values exceeding 30 pg/ml as a “positive” sensitization reaction [33], no correlation was found with peri-implantitis.

Discussion

Within the test-control setting of the present study on 48 patients no correlation was observed between clinical peri-implantitis parameters and laboratory parameters related to tissue macrophage sensitization. Likewise, bacterial levels for eleven so-called key pathogens were not associated to any of the laboratory parameters assessed. Consequently, the study hypothesis was rejected. In the test group, peri-implantitis was confirmed by the presence of pockets exceeding 4 mm with bleeding upon gentle probing, while control patients generally exhibited healthy sites without bleeding. Concentrations of IgA, MBL, tnf-α and IL1ß were generally elevated and exceeding the reference levels [34]. The CPM values in both groups were relatively low, with most cases (65%) scoring 0 and 1 out of 4. With aMMP-8 levels around 30 ng/ml in both groups the values were in a range reported for sites with peri-implant mucositis and lower than those that have been previously been reported to be associated with peri-implantitis [35]. These levels were also close to those observed in patients with periodontitis grades b and c [36], thereby underpinning the clinical findings. In this context, the fact that the participants in the present study were recruited from a cohort of patients with a history of periodontitis undergoing periodontal maintenance therapy may explain the generally elevated levels of cytokines and inflammation markers, Even if perfectly controlled as stated in the inclusion criteria, inflammation parameters in patients with a history of periodontitis, thus proving to be susceptible to an enhanced inflammatory reaction might still be altered as compared to patients without previous periodontal issues. Important to state, however, briefv that this refers to both, test and control group.

Published data on polymorphisms in the encoding regions for the involved cytokines present inconsistent findings. In the present study no intergroup differences were observed in terms of altered gene polymorphisms encoding for IL1α, IL1ß or the concentration of these cytokines. A recent cross-sectional study conducted in Portugal corrobated these findings concerning the investigated polymorphisms encoding for both IL-1α and ß in implant patients with and without peri-implantitis [37]. On the other hand, a recent case-control study involving 120 individuals with healthy implants and peri-implantitis found that the polymorphism in the IL-1ß receptor antagonist was more prevalent in the group of peri-implantitis patients (OR 3), although no statistically significant differences were observed in the proportion of altered alleles for IL-1β between the groups.

A recent retrospective study investigating TO2 sensitization demonstrated a significant correlation with an odds ratio of 19 for clinical symptoms of peri-implantitis correlated to positive testing for TiO2 sensitization [33]. However, in this study, “positive” was defined as tnf-α values exceeding 40 pg/ml or IL-1ß values exceeding 30 pg/ml. In contrast, the present data analysis did not reveal such a correlation.

The present study has two major limitations. Although a total of 49 patients provided sufficient power to properly test the hypothesis regarding relevant differences in blood parameters between the groups, the power might be insufficient to make a general statement about the degree to which respective cytokines, aMMP-8, MBL or inflammation-related polymorphisms are correlated with peri-implantitis. On this behalf and to address this question conclusively, large-scale studies are needed. More specifically, such studies should ensure not only the proper comparability of test and control groups, standardized and well-calibrated clinical measurements, and adequate statistical power, but they should also include patients without a history of periodontitis and cases with more advanced peri-implantitis. A multi-center approach involving centers from different countries and involving patients with different oral treatment needs may help minimizing the potential risk of bias.

Furthermore it is important to underline, that peri-implantitis is a multi-factorial disease, with biofilm as the primary etiologic factor and a large variety of confirmed and unconfirmed risk factors [38, 39]. Accordingly, the complex and highly individual host response in each specific patient involves multiple immunological and environmental factors. While testing for specific gene polymorphisms may be reductionist on one hand, the present design and study aim are important to shed a light on the potential relevance of this specific factor. In this context the present study design with a balanced distribution of age and sex provides the best preconditions possible to assess another valuable piece of the whole puzzle of the peri-implant foreign body reaction, reflecting the interrelationship between individual immunological host response and the phenomenon of peri-implantitis.

The moderate degree of peri-implant inflammation might be considered another limitation of the present study. In fact, test implants were not of hopeless prognosis, what might have rendered the investigation more sensitive, thus creating a more significant intergroup difference. Nevertheless, the actual inclusion criteria might better reflect everyday clinical reality with peri-implantitis at an early and implants that are still reasonable-to-treat.

Several tested bacterial species exhibited significant differences between the groups. Although comprehensive systematic reviews have failed to identify a specific microbiome associated with peri-implantitis [40, 41], the finding that T. forsythensis, T. denticola and Fusobacterium spp. were more frequently in the peri-implantitis group aligns with reports of a higher relative abundance and broader diversity of the flora in peri-implantitis sites [41].

Laboratory assessments of MMP-8, the specifically encoding gene areas and finally the bacterial assessment are – strictly speaking - neither clinical nor parameters directly related to macrophage sensitization. However, these data were collected for two reasons: Firstly, to allow for a more comprehensive illustration of the host, the peri-implant tissues and the composition of the peri-implant biofilm. Secondly, the respective laboratory provides these tests and suggest investigating these parameters likewise, when the blood samples sent for analysis. Within the present study, however, these parameters failed to provide clinically relevant information.

Taken together, with a missing correlation of clinical and laboratory parameters, the data from the present study do not suggest that the respective immunologic analysis provides benefits in terms of a prognostic value for the assessment of the risk for peri-implantitis.

Conclusion

In the present case-control study the parameters related to TiO2-sensitization consistently demonstrated no association with clinical symptoms of peri-implantitis. Within the limitations of this study, these tests do not appear to hold predictive large-scale studies should be conducted to investigate whether testing tissue macrophage sensitization can aid in assessing the individual risk for peri-implantitis.

Acknowledgements

Clinic ZPZ of Zurich University funded the clinical assessment and blood sampling. The Swiss Society for Environmental Dentistry (Schweizerische Gesellschaft für UmweltZahnMedizin) funded the overnight transport of the samples and laboratory analysis at the Institut für medizinische Diagnostik Berlin (IMD). The authors express their gratitude to Dr. Sabine Schütt from IMD for her help with the description of the various tests for diverse laboratory parameters.

Author contributions

PS, PRS and JT designed the study, PS performed clinical measurements and sampling, PS and PRS wrote the main text and performed the statistical analysis, JT revised the main text.

Funding

The Swiss Society for Environmental Dentistry (Schweizerische Gesellschaft für UmweltZahnMedizin) funded the overnight transport of the samples and laboratory analysis at the Institut für Medizinische Diagnostik Berlin (IMD).

Open access funding provided by University of Basel

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethics approval and consent to participate

Prior to study start an ethics approval was obtained by the Ethical Committee of the Canton of Zurich (KEK-ZH-Nr. 2014 − 0133). Patients were informed about the aim of the study and the respective study-specific measures, and eventually gave their written consent to participate. Patient participation was strictly voluntary.

Consent for publication

The authors give their consent for the publication of identifiable details, which can include figures and tables within the manuscript and the text itself to be published in Clin Oral Investigations.

Competing interests

The authors declare no competing interests.

The original version of this article was revised: This article was originally published with a misspelled author name. It should be Tartsch.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Change history

9/20/2024

A Correction to this paper has been published: 10.1007/s00784-024-05948-0
==== Refs
References

1. Adler L Buhlin K Jansson L Survival and complications: a 9- to 15-year retrospective follow-up of dental implant therapy J Oral Rehabil 2020 47 1 67 77 10.1111/joor.12866 31359446
Adler L, Buhlin K, Jansson L (2020) Survival and complications: a 9- to 15-year retrospective follow-up of dental implant therapy. J Oral Rehabil 47(1):67–7731359446
2. Moraschini V Poubel LA Ferreira VF Barboza Edos S Evaluation of survival and success rates of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review Int J Oral Maxillofac Surg 2015 44 3 377 388 10.1016/j.ijom.2014.10.023 25467739
Moraschini V, Poubel LA, Ferreira VF, Barboza Edos S (2015) Evaluation of survival and success rates of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review. Int J Oral Maxillofac Surg 44(3):377–38825467739
3. Schwartz-Arad D Kidron N Dolev E A long-term study of implants supporting overdentures as a model for implant success J Periodontol 2005 76 9 1431 1435 10.1902/jop.2005.76.9.1431 16171428
Schwartz-Arad D, Kidron N, Dolev E (2005) A long-term study of implants supporting overdentures as a model for implant success. J Periodontol 76(9):1431–143516171428
4. Baj A Lo Muzio L Lauritano D Candotto V Mancini GE Gianni AB Success of immediate versus standard loaded implants: a short literature review J Biol Regul Homeost Agents 2016 30 2 Suppl 1 183 188 27469567
Baj A, Lo Muzio L, Lauritano D, Candotto V, Mancini GE, Gianni AB (2016) Success of immediate versus standard loaded implants: a short literature review. J Biol Regul Homeost Agents 30(2 Suppl 1):183–18827469567
5. Jung RE Zembic A Pjetursson BE Zwahlen M Thoma DS Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years Clin Oral Implants Res 2012 23 Suppl 6 2 21 10.1111/j.1600-0501.2012.02547.x 23062124
Jung RE, Zembic A, Pjetursson BE, Zwahlen M, Thoma DS (2012) Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years. Clin Oral Implants Res 23(Suppl 6):2–2123062124
6. Liaw K Delfini RH Abrahams JJ Dental Implant complications Semin Ultrasound CT MR 2015 36 5 427 433 10.1053/j.sult.2015.09.007 26589696
Liaw K, Delfini RH, Abrahams JJ (2015) Dental Implant complications. Semin Ultrasound CT MR 36(5):427–43326589696
7. Pjetursson BE Heimisdottir K Dental implants - are they better than natural teeth? Eur J Oral Sci 2018 126 Suppl 1 81 87 10.1111/eos.12543 30178552
Pjetursson BE, Heimisdottir K (2018) Dental implants - are they better than natural teeth? Eur J Oral Sci 126(Suppl 1):81–8730178552
8. Kwon T Wang CW Salem DM Levin L Nonsurgical and surgical management of biologic complications around dental implants: peri-implant mucositis and peri-implantitis Quintessence Int 2020 51 10 810 820 32577710
Kwon T, Wang CW, Salem DM, Levin L (2020) Nonsurgical and surgical management of biologic complications around dental implants: peri-implant mucositis and peri-implantitis. Quintessence Int 51(10):810–82032577710
9. Heitz-Mayfield LJ Aaboe M Araujo M Carrion JB Cavalcanti R Cionca N Cochran D Darby I Funakoshi E Gierthmuehlen PC Group 4 ITI Consensus Report: risks and biologic complications associated with implant dentistry Clin Oral Implants Res 2018 29 Suppl 351 358 10.1111/clr.13307 30328181
Heitz-Mayfield LJ, Aaboe M, Araujo M, Carrion JB, Cavalcanti R, Cionca N, Cochran D, Darby I, Funakoshi E, Gierthmuehlen PC et al (2018) Group 4 ITI Consensus Report: risks and biologic complications associated with implant dentistry. Clin Oral Implants Res 29(Suppl):351–35830328181
10. Klinge B Klinge A Bertl K Stavropoulos A Peri-implant diseases Eur J Oral Sci 2018 126 Suppl 1 88 94 10.1111/eos.12529 30178555
Klinge B, Klinge A, Bertl K, Stavropoulos A (2018) Peri-implant diseases. Eur J Oral Sci 126(Suppl 1):88–9430178555
11. Derks J Tomasi C Peri-implant health and disease. A systematic review of current epidemiology J Clin Periodontol 2015 42 Suppl 16 S158 171 25495683
Derks J, Tomasi C (2015) Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol 42(Suppl 16):S158–17125495683
12. Roccuzzo A Imber JC Marruganti C Salvi GE Ramieri G Roccuzzo M Clinical outcomes of dental implants in patients with and without history of periodontitis: a 20-year prospective study J Clin Periodontol 2022 49 12 1346 1356 10.1111/jcpe.13716 36054302
Roccuzzo A, Imber JC, Marruganti C, Salvi GE, Ramieri G, Roccuzzo M (2022) Clinical outcomes of dental implants in patients with and without history of periodontitis: a 20-year prospective study. J Clin Periodontol 49(12):1346–135636054302
13. Sanz M Chapple IL Working Group 4 of the VEWoP Clinical research on peri-implant diseases: consensus report of Working Group 4 J Clin Periodontol 2012 39 Suppl 12 202 206 10.1111/j.1600-051X.2011.01837.x 22533957
Sanz M, Chapple IL, Working Group 4 of the VEWoP (2012) Clinical research on peri-implant diseases: consensus report of Working Group 4. J Clin Periodontol 39(Suppl 12):202–20622533957
14. Sanz M, Klinge B, Alcoforado G, Bienz SP, Cosyn J, De Bruyn H, Derks J, Figuero E, Gurzawska K, Heitz-Mayfield L et al (2018) Biological aspects: Summary and consensus statements of group 2. The 5(th) EAO Consensus Conference 2018. Clin Oral Implants Res 29 Suppl 18:152–156
15. Dreyer H Grischke J Tiede C Eberhard J Schweitzer A Toikkanen SE Glockner S Krause G Stiesch M Epidemiology and risk factors of peri-implantitis: a systematic review J Periodontal Res 2018 53 5 657 681 10.1111/jre.12562 29882313
Dreyer H, Grischke J, Tiede C, Eberhard J, Schweitzer A, Toikkanen SE, Glockner S, Krause G, Stiesch M (2018) Epidemiology and risk factors of peri-implantitis: a systematic review. J Periodontal Res 53(5):657–68129882313
16. Mombelli A Hashim D Cionca N What is the impact of titanium particles and biocorrosion on implant survival and complications? A critical review Clin Oral Implants Res 2018 29 Suppl 18 37 53 10.1111/clr.13305 30306693
Mombelli A, Hashim D, Cionca N (2018) What is the impact of titanium particles and biocorrosion on implant survival and complications? A critical review. Clin Oral Implants Res 29(Suppl 18):37–5330306693
17. Han CH Johansson CB Wennerberg A Albrektsson T Quantitative and qualitative investigations of surface enlarged titanium and titanium alloy implants Clin Oral Implants Res 1998 9 1 1 10 10.1034/j.1600-0501.1998.090101.x 9590939
Han CH, Johansson CB, Wennerberg A, Albrektsson T (1998) Quantitative and qualitative investigations of surface enlarged titanium and titanium alloy implants. Clin Oral Implants Res 9(1):1–109590939
18. Pajarinen J Kouri VP Jamsen E Li TF Mandelin J Konttinen YT The response of macrophages to titanium particles is determined by macrophage polarization Acta Biomater 2013 9 11 9229 9240 10.1016/j.actbio.2013.06.027 23827094
Pajarinen J, Kouri VP, Jamsen E, Li TF, Mandelin J, Konttinen YT (2013) The response of macrophages to titanium particles is determined by macrophage polarization. Acta Biomater 9(11):9229–924023827094
19. Bosshardt DD Chappuis V Buser D Osseointegration of titanium, titanium alloy and zirconia dental implants: current knowledge and open questions Periodontol 2000 2017 73 1 22 40 10.1111/prd.12179 28000277
Bosshardt DD, Chappuis V, Buser D (2017) Osseointegration of titanium, titanium alloy and zirconia dental implants: current knowledge and open questions. Periodontol 2000 73(1):22–4028000277
20. Delgado-Ruiz R, Romanos G (2018) Potential Causes of Titanium Particle and Ion Release in Implant Dentistry: a systematic review. Int J Mol Sci 19(11)
21. Jacobi-Gresser E Huesker K Schutt S Genetic and immunological markers predict titanium implant failure: a retrospective study Int J Oral Maxillofac Surg 2013 42 4 537 543 10.1016/j.ijom.2012.07.018 22925444
Jacobi-Gresser E, Huesker K, Schutt S (2013) Genetic and immunological markers predict titanium implant failure: a retrospective study. Int J Oral Maxillofac Surg 42(4):537–54322925444
22. Nakashima Y Sun DH Trindade MC Maloney WJ Goodman SB Schurman DJ Smith RL Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro J Bone Joint Surg Am 1999 81 5 603 615 10.2106/00004623-199905000-00002 10360689
Nakashima Y, Sun DH, Trindade MC, Maloney WJ, Goodman SB, Schurman DJ, Smith RL (1999) Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg Am 81(5):603–61510360689
23. Laine ML Leonhardt A Roos-Jansaker AM Pena AS van Winkelhoff AJ Winkel EG Renvert S IL-1RN gene polymorphism is associated with peri-implantitis Clin Oral Implants Res 2006 17 4 380 385 10.1111/j.1600-0501.2006.01249.x 16907768
Laine ML, Leonhardt A, Roos-Jansaker AM, Pena AS, van Winkelhoff AJ, Winkel EG, Renvert S (2006) IL-1RN gene polymorphism is associated with peri-implantitis. Clin Oral Implants Res 17(4):380–38516907768
24. Ceramic implants [https://www.zsystems.com/de/]
25. Kim KT Eo MY Nguyen TTH Kim SM General review of titanium toxicity Int J Implant Dent 2019 5 1 10 10.1186/s40729-019-0162-x 30854575
Kim KT, Eo MY, Nguyen TTH, Kim SM (2019) General review of titanium toxicity. Int J Implant Dent 5(1):1030854575
26. Javed F Al-Hezaimi K Almas K Romanos GE Is titanium sensitivity associated with allergic reactions in patients with dental implants? A systematic review Clin Implant Dent Relat Res 2013 15 1 47 52 10.1111/j.1708-8208.2010.00330.x 21414135
Javed F, Al-Hezaimi K, Almas K, Romanos GE (2013) Is titanium sensitivity associated with allergic reactions in patients with dental implants? A systematic review. Clin Implant Dent Relat Res 15(1):47–5221414135
27. Siddiqi A Payne AGT De Silva RK Duncan WJ Titanium allergy: could it affect dental implant integration? Clin Oral Implants Res 2011 22 7 673 680 10.1111/j.1600-0501.2010.02081.x 21251079
Siddiqi A, Payne AGT, De Silva RK, Duncan WJ (2011) Titanium allergy: could it affect dental implant integration? Clin Oral Implants Res 22(7):673–68021251079
28. Liao J Li C Wang Y Ten M Sun X Tian A Zhang Q Liang X Meta-analysis of the association between common interleukin-1 polymorphisms and dental implant failure Mol Biol Rep 2014 41 5 2789 2798 10.1007/s11033-014-3133-6 24452718
Liao J, Li C, Wang Y, Ten M, Sun X, Tian A, Zhang Q, Liang X (2014) Meta-analysis of the association between common interleukin-1 polymorphisms and dental implant failure. Mol Biol Rep 41(5):2789–279824452718
29. Bioque G Crusius JB Koutroubakis I Bouma G Kostense PJ Meuwissen SG Pena AS Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease Clin Exp Immunol 1995 102 2 379 383 10.1111/j.1365-2249.1995.tb03793.x 7586694
Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS (1995) Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 102(2):379–3837586694
30. di Giovine FS Takhsh E Blakemore AI Duff GW Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta) Hum Mol Genet 1992 1 6 450 10.1093/hmg/1.6.450 1301918
di Giovine FS, Takhsh E, Blakemore AI, Duff GW (1992) Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1(6):4501301918
31. McDowell TL Symons JA Ploski R Forre O Duff GW A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism Arthritis Rheum 1995 38 2 221 228 10.1002/art.1780380210 7848312
McDowell TL, Symons JA, Ploski R, Forre O, Duff GW (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 38(2):221–2287848312
32. Mansfield JC Holden H Tarlow JK Di Giovine FS McDowell TL Wilson AG Holdsworth CD Duff GW Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist Gastroenterology 1994 106 3 637 642 10.1016/0016-5085(94)90696-3 8119534
Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106(3):637–6428119534
33. Stolzer C Muller M Gosau M Henningsen A Fuest S Aavani F Smeets R Do Titanium Dioxide particles stimulate macrophages to release Proinflammatory cytokines and increase the risk for peri-implantitis? J Oral Maxillofac Surg 2023 81 3 308 317 10.1016/j.joms.2022.10.019 36442535
Stolzer C, Muller M, Gosau M, Henningsen A, Fuest S, Aavani F, Smeets R (2023) Do Titanium Dioxide particles stimulate macrophages to release Proinflammatory cytokines and increase the risk for peri-implantitis? J Oral Maxillofac Surg 81(3):308–31736442535
34. Lyons HE, Arman BM, Robertson SA, Sharkey DJ (2023) Immune regulatory cytokines in seminal plasma of healthy men: A scoping review and analysis of variance. Andrology
35. Xanthopoulou V, Raisanen I, Sorsa T, Sakellari D (2022) Active MMP-8 as a biomarker of Peri-implant Health or Disease. Eur J Dent
36. Umeizudike K Raisanen I Gupta S Nwhator S Grigoriadis A Sakellari D Sorsa T Active matrix metalloproteinase-8: a potential biomarker of oral systemic link Clin Exp Dent Res 2022 8 1 359 365 10.1002/cre2.516 34800007
Umeizudike K, Raisanen I, Gupta S, Nwhator S, Grigoriadis A, Sakellari D, Sorsa T (2022) Active matrix metalloproteinase-8: a potential biomarker of oral systemic link. Clin Exp Dent Res 8(1):359–36534800007
37. Cardoso JM Ribeiro AC Palos C Proenca L Noronha S Alves RC Association between IL-1A and IL-1B gene polymorphisms with peri-implantitis in a Portuguese population-a pilot study PeerJ 2022 10 e13729 10.7717/peerj.13729 35855430
Cardoso JM, Ribeiro AC, Palos C, Proenca L, Noronha S, Alves RC (2022) Association between IL-1A and IL-1B gene polymorphisms with peri-implantitis in a Portuguese population-a pilot study. PeerJ 10:e1372935855430
38. Darby I Risk factors for periodontitis & peri-implantitis Periodontol 2000 2022 90 1 9 12 10.1111/prd.12447 35913624
Darby I (2022) Risk factors for periodontitis & peri-implantitis. Periodontol 2000 90(1):9–1235913624
39. Sun TC, Chen CJ, Gallucci GO (2023) Prevention and management of peri-implant disease. Clin Implant Dent Relat Res
40. Sahrmann P, Gilli F, Wiedemeier DB, Attin T, Schmidlin PR, Karygianni L (2020) The Microbiome of Peri-implantitis: a systematic review and Meta-analysis. Microorganisms 8(5)
41. de Melo F Milanesi FC Angst PDM Oppermann RV A systematic review of the microbiota composition in various peri-implant conditions: data from 16S rRNA gene sequencing Arch Oral Biol 2020 117 104776 10.1016/j.archoralbio.2020.104776 32512257
de Melo F, Milanesi FC, Angst PDM, Oppermann RV (2020) A systematic review of the microbiota composition in various peri-implant conditions: data from 16S rRNA gene sequencing. Arch Oral Biol 117:10477632512257
